Literature DB >> 14688320

Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines.

Brock L Schweitzer1, Rodney P DeKoter.   

Abstract

A number of presumptive target genes for the Ets-family transcription factor PU.1 have been identified in the B cell lineage. However, the precise function of PU.1 in B cells has not been studied because targeted null mutation of the PU.1 gene results in a block to lymphomyeloid development at an early developmental stage. In this study, we take advantage of recently developed PU.1(-/-)Spi-B(-/-) IL-7 and stromal cell-dependent progenitor B (pro-B) cell lines to analyze the function of PU.1 and Spi-B in B cell development. We show that contrary to previously published expectations, PU.1 and/or Spi-B are not required for Ig H chain (IgH) gene transcription in pro-B cells. In fact, PU.1(-/-)Spi-B(-/-) pro-B cells have increased levels of IgH transcription compared with wild-type pro-B cells. In addition, high levels of Igkappa transcription are induced after IL-7 withdrawal of wild-type or PU.1(-/-)Spi-B(-/-) pro-B cells. In contrast, we found that Iglambda transcription is reduced in PU.1(-/-)Spi-B(-/-) pro-B cells relative to wild-type pro-B cells after IL-7 withdrawal. These results suggest that Iglambda, but not IgH or Igkappa, transcription, is dependent on PU.1 and/or Spi-B. The PU.1(-/-)Spi-B(-/-) pro-B cells have other phenotypic changes relative to wild-type pro-B cells including increased proliferation, increased CD25 expression, decreased c-Kit expression, and decreased RAG-1 expression. Taken together, our observations suggest that reduction of PU.1 and/or Spi-B activity in pro-B cells promotes their differentiation to a stage intermediate between late pro-B cells and large pre-B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688320     DOI: 10.4049/jimmunol.172.1.144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

2.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

3.  E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.

Authors:  Adam S Lazorchak; Mark S Schlissel; Yuan Zhuang
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling.

Authors:  Xiang Zhu; Brock L Schweitzer; Eric J Romer; Courtney E W Sulentic; Rodney P DeKoter
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

5.  Janus Kinase Mutations in Mice Lacking PU.1 and Spi-B Drive B Cell Leukemia through Reactive Oxygen Species-Induced DNA Damage.

Authors:  Michelle Lim; Carolina R Batista; Bruno R de Oliveira; Rachel Creighton; Jacob Ferguson; Kurt Clemmer; Devon Knight; James Iansavitchous; Danish Mahmood; Mariano Avino; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2020-08-28       Impact factor: 4.272

6.  Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.

Authors:  Gang-Ming Zou; Jian-Jun Chen; Mervin C Yoder; Wei Wu; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

7.  A role for interferon regulatory factor 4 in receptor editing.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; Runqing Lu
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

8.  Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing.

Authors:  Li Bai; Yuhong Chen; Yinghong He; Xuezhi Dai; Xueyan Lin; Renren Wen; Demin Wang
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

9.  Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.

Authors:  Isaac B Houston; Meghana B Kamath; Brock L Schweitzer; Timothy M Chlon; Rodney P DeKoter
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

Review 10.  Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.

Authors:  Rodney P DeKoter; Meghana B Kamath; Isaac B Houston
Journal:  Blood Cells Mol Dis       Date:  2007-07-13       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.